1.Executive Summary
1.1. Regional Market Share
1.2.Business Trends
1.3. Cardiac Biomarkers Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1.Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4.Primary Research
2.5.Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1.Market Definition
3.2.Cardiac Biomarkers Market: COVID-19 Impact
3.3. Key Segmentations
3.4.Key Developments
3.5.Allied Industry Data
4.Cardiac Biomarkers Market – Industry Insights
4.1. Industry Segmentation
4.2.COVID-19 overview of world economy
4.3.Industry Ecosystem Channel Analysis
4.4.Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1.Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4.Market Restraints
7.5. Market Trends
8.Risk Analysis
9. Market Analysis
9.1.Porter's Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10.Cardiac Biomarkers Market
10.1.Overview
10.2. Historical Analysis (2018-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. Cardiac Biomarkers Market Size & Forecast 2024A-2034F
11.1. Overview
11.2.Key Findings
11.3.Market Segmentation
11.3.1.By Type
11.3.1.1. Creatine Kinase-MB (CK-MB)
11.3.1.1.1.By Value (USD Million) 2024A-2034F
11.3.1.1.2. Market Share (%) 2024A-2034F
11.3.1.1.3. Y-o-Y Growth (%) 2024A-2034F
11.3.1.2.Troponin
11.3.1.2.1. By Value (USD Million) 2024A-2034F
11.3.1.2.2.Market Share (%) 2024A-2034F
11.3.1.2.3.Y-o-Y Growth (%) 2024A-2034F
11.3.1.3.B-type Natriuretic Peptide (BNP)
11.3.1.3.1. By Value (USD Million) 2024A-2034F
11.3.1.3.2.Market Share (%) 2024A-2034F
11.3.1.3.3.Y-o-Y Growth (%) 2024A-2034F
11.3.1.4.N-terminal Pro-BNP (NT-proBNP)
11.3.1.4.1. By Value (USD Million) 2024A-2034F
11.3.1.4.2.Market Share (%) 2024A-2034F
11.3.1.4.3.Y-o-Y Growth (%) 2024A-2034F
11.3.1.5.Others
11.3.1.5.1. By Value (USD Million) 2024A-2034F
11.3.1.5.2.Market Share (%) 2024A-2034F
11.3.1.5.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2. By Application
11.3.2.1.Acute Coronary Syndrome
11.3.2.1.1. By Value (USD Million) 2024A-2034F
11.3.2.1.2.Market Share (%) 2024A-2034F
11.3.2.1.3.Y-o-Y Growth (%) 2024A-2034F
11.3.2.2. Myocardial Infarction
11.3.2.2.1.By Value (USD Million) 2024A-2034F
11.3.2.2.2. Market Share (%) 2024A-2034F
11.3.2.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.3. Congestive Heart Failure
11.3.2.3.1.By Value (USD Million) 2024A-2034F
11.3.2.3.2. Market Share (%) 2024A-2034F
11.3.2.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.2.4. Others
11.3.2.4.1.By Value (USD Million) 2024A-2034F
11.3.2.4.2. Market Share (%) 2024A-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3.By End User
11.3.3.1.Hospitals
11.3.3.1.1. By Value (USD Million) 2024A-2034F
11.3.3.1.2.Market Share (%) 2024A-2034F
11.3.3.1.3.Y-o-Y Growth (%) 2024A-2034F
11.3.3.2. Point of Care Testing
11.3.3.2.1.By Value (USD Million) 2024A-2034F
11.3.3.2.2. Market Share (%) 2024A-2034F
11.3.3.2.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3.3. Laboratory Testing
11.3.3.3.1.By Value (USD Million) 2024A-2034F
11.3.3.3.2. Market Share (%) 2024A-2034F
11.3.3.3.3. Y-o-Y Growth (%) 2024A-2034F
11.3.3.4. Diagnostic Centers
11.3.3.4.1.By Value (USD Million) 2024A-2034F
11.3.3.4.2. Market Share (%) 2024A-2034F
11.3.3.4.3. Y-o-Y Growth (%) 2024A-2034F
12.North America Cardiac Biomarkers Market Size & Forecast 2024A-2034F
12.1.Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1.By Type
12.3.2. By Application
12.3.3. By End User
12.4. Country
12.4.1. United States
12.4.2. Canada
13.Europe Cardiac Biomarkers Market Size & Forecast 2024A-2034F
13.1.Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Type
13.3.2. By Application
13.3.3. By End User
13.4.Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14.Asia-Pacific Cardiac Biomarkers Market Size & Forecast 2024A-2034F
14.1. Overview
14.2. Key Findings
14.3.Market Segmentation
14.3.1.By Type
14.3.2. By Application
14.3.3. By End User
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15.Middle East and Africa Cardiac Biomarkers Market Size & Forecast 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Type
15.3.2. By Application
15.3.3. By End User
15.4.Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4.South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Cardiac Biomarkers Market Size & Forecast 2024A-2034F
16.1.Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1.By Type
16.3.2. By Application
16.3.3. By End User
16.4. Country
16.4.1.Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1.Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. Abbott Laboratories
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2.Key Clients
18.1.4.3.Market Share
18.1.4.4.Recent News & Development (Last 3 Yrs.)
18.2. Becton, Dickinson and Company
18.3. Luminex Corporation
18.4. Roche Diagnostics
18.5. PerkinElmer, Inc.
18.6. Bio-Rad Laboratories, Inc.
18.7. bioMérieux SA
18.8. Fujirebio
18.9. Beckman Coulter
18.10.ACON Laboratories, Inc.
18.11.Ortho Clinical Diagnostics
18.12. Siemens Healthineers
18.13. Randox Laboratories Ltd.
18.14.Trinity Biotech
18.15. Thermo Fisher Scientific Inc.
18.16. Other Prominent Players
19. Appendix
20.Consultant Recommendation